Clinical Trial Update: Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

View source ↗

Summary

A clinical trial update shows a study evaluating tralokinumab for moderate-to-severe atopic dermatitis with genital involvement is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region | Status: RECRUITING